All Stories

  1. Bleeding after antiplatelet therapy for the treatment of acute coronary syndromes: a review of the evidence and evolving paradigms

    Article • Expert Opinion on Drug Safety, October 2019, Taylor & Francis

    Stefan James, Dr Dominick J Angiolillo

  2. Aspirin for the primary prevention of cardiovascular disease: latest evidence

    Article • Expert Review of Cardiovascular Therapy, August 2019, Taylor & Francis

    Dr Dominick J Angiolillo

  3. Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations

    Article • Therapeutic Advances in Hematology, January 2019, SAGE Publications

    Dr Dominick J Angiolillo

  4. CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction

    Article • Expert Opinion on Investigational Drugs, November 2018, Taylor & Francis

    Dr Dominick J Angiolillo

  5. Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery disease

    Article • Expert Opinion on Drug Safety, September 2018, Taylor & Francis

    Dr Dominick J Angiolillo, Sergio Buccheri

  6. Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study

    Article • Clinical Cardiology, August 2018, Wiley

    Dr Dominick J Angiolillo, Prof. Giuseppe Biondi-Zoccai

  7. The role of oral anticoagulant therapy in patients with acute coronary syndrome

    Article • Therapeutic Advances in Hematology, October 2017, SAGE Publications

    Dr Dominick J Angiolillo

  8. Role of genetic testing in patients undergoing percutaneous coronary intervention

    Article • Expert Review of Clinical Pharmacology, October 2017, Taylor & Francis

    Dr Dominick J Angiolillo

  9. Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, May 2017, SAGE Publications

    Dr Dominick J Angiolillo

  10. Head to head comparison of prasugrel vs ticagrelor

    Article • European Heart Journal, February 2016, European Society of Cardiology

    Dr Dominick J Angiolillo

  11. Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar

    Article • Vascular Health and Risk Management, April 2014, Taylor & Francis

    Dr Dominick J Angiolillo